Stevens Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Nevirapine among HIV-Infected Pregnant Women: Five Cases
Introduction: The nevirapine is the most widely accused drug in toxidermias in patients living with HIV. It is
responsible for toxic epidermal necrolysis called Lyell syndrome or Stevens Johnson syndrome, severe during
pregnancy. We report five cases in pregnant women who are HIV-positive.
Case reports: Five pregnant women aged 35 years on average with a mean gestational age of 29.6 weeks
of amenorrhea were HIV1-positive.The mean CD4 count was 416/mm3. They had severe toxidermia such as Lyell
syndrome or Stevens Johnson syndrome. These toxidermias appeared on average 26 days after taking antiretroviral
triple therapy including nevirapine as part of the prevention of mother-to-child transmission of HIV (PMTCT). The
outcome was favorable after discontinuation of antiretrovirals. Nevirapine was substituted with lopinavir/ritonavir.
Newborns had received antiretroviral prophylaxis and were not infected with HIV.
Conclusion: The nevirapine toxidermia is common during antiretroviral therapy. These toxidermia are severe
during pregnancy related to maternal and fetal vital risks. The replacement of nevirapine with an anti-protease is a
therapeutic alternative in our resource-limited countries.
Auteur(s) : Diatta BA, Gassama O, Diadie S, Diallo M, Niang SO, Ndiaye M, Diop A, Ly F, Dieng MT.
Pages : 1-3
Année de publication : 2017
Revue : Journal of AIDS & Clinical Research
N° de volume : 8-8
Type : Article
Mise en ligne par : DIATTA Boubacar Ahy